The present invention pertains to intracorporal medical devices, for example, intravascular guidewires, catheters, and the like as well as improved methods for manufacturing and using such medical devices. More particularly, the invention relates to an elongate tubular member including a tapered transition portion, and medical devices including such a tubular member.
A wide variety of intracorporeal medical devices have been developed for medical use, for example, intravascular use. Some of these devices include guidewires, catheters, and the like. Of the known medical devices, each has certain advantages and disadvantages. There is an ongoing need to provide alternative medical devices as well as alternative methods for manufacturing and using medical devices.
The invention provides design, material, and manufacturing method alternatives for intracorporal medical devices. An example embodiment includes a tubular member including a tapered transition region disposed between two sections having different physical characteristics, such as flexibility characteristics. Some example embodiments include a medical device including such a tubular member. Some of these and other features and characteristics of some example inventive devices and methods are described in more detail below.
The above summary of some embodiments is not intended to describe each disclosed embodiment or every implementation of the present invention. The Figures, and Detailed Description, which follow, more particularly exemplify these embodiments.
The invention may be more completely understood in consideration of the following detailed description of various embodiments of the invention in connection with the accompanying drawings, in which:
While the invention is amenable to various modifications and alternative forms, specifics thereof have been shown by way of example in the drawings and will be described in detail. It should be understood, however, that the intention is not to limit the invention to the particular embodiments described. On the contrary, the intention is to cover all modifications, equivalents, and alternatives falling within the spirit and scope of the invention.
For the following defined terms, these definitions shall be applied, unless a different definition is given in the claims or elsewhere in this specification.
All numeric values are herein assumed to be modified by the term “about,” whether or not explicitly indicated. The term “about” generally refers to a range of numbers that one of skill in the art would consider equivalent to the recited value (i.e., having the same function or result). In many instances, the terms “about” may include numbers that are rounded to the nearest significant figure.
The recitation of numerical ranges by endpoints includes all numbers within that range (e.g. 1 to 5 includes 1, 1.5, 2, 2.75, 3, 3.80, 4, and 5).
As used in this specification and the appended claims, the singular forms “a”, “an”, and “the” include plural referents unless the content clearly dictates otherwise. As used in this specification and the appended claims, the term “or” is generally employed in its sense including “and/or” unless the content clearly dictates otherwise.
The following detailed description should be read with reference to the drawings in which similar elements in different drawings are numbered the same. The drawings, which are not necessarily to scale, depict illustrative embodiments and are not intended to limit the scope of the invention.
Because medical devices may need to navigate the tortuous anatomy, there are a number of design considerations that are often contemplated when manufacturing medical devices like guidewire 10 and/or catheter 16. For example, it may be desirable to design medical devices that have a generally soft or rounded distal tip so as to reduce the trauma that could otherwise be associated with interactions between the medical device and a blood vessel. In addition, it is often desirable for at least the distal region of the medical device to be highly flexible so that it can bend while navigating the vasculature. Moreover, because medical devices are often inserted into the body at a location that is a distance from the target site, medical devices are typically designed with sufficient column strength so that a clinician can push the device at a proximal location and have it advance into and through the vasculature. This design consideration, often termed “pushability”, may be embodied by a generally stiff proximal section of the medical device. In addition, because it may be desirable for a clinician to apply torque at one end of the device and have the torque translate to the other end, for example when advancing and/or navigating the device through the anatomy, medical devices are often designed to possess a certain level of “torquability” or the ability to transmit torque from the proximal end to the distal end.
The medical devices disclosed herein may take into account these and other design considerations. Accordingly, in some embodiments, to the extent applicable, the example medical devices disclosed herein may generally include structural features that may contribute to some of these characteristics. While the discussion found below is generally attributed to guidewire 10, it should be noted that the invention is not intended to be limited to guidewires as numerous other medical devices are contemplated. For example, the device may comprise a catheter (e.g., therapeutic, diagnostic, or guide catheter) like catheter 16, or catheters 610 and 710 discussed below, or an endoscopic device, a laproscopic device, a stent, an embolic or distal protection device, or any other suitable device.
Turning now to
A sheath or covering 22 may be disposed over portions or all of core wire 18 and/or tubular member 20 that may define a generally smooth outer surface for guidewire 10. In other embodiments, however, such a sheath or covering 22 may be absent from a portion or all of guidewire 10, such that tubular member 20 and/or core wire 18 may form the outer surface. In
In at least some embodiments, tubular member 20 includes a first section 20a, a tapered section 20b, and a slotted section 20c. In general, the longitudinal arrangement of sections 20a/20b/20c can be as shown in
As the name implies, slotted section 20c can include a plurality of slots 24 formed therein. In some embodiments, only section 20c includes slots 24 and sections 20a/20b are free of slots 24. In other embodiments, section 20a, section 20b, or both may include one or more slots 24.
Slots 24 may be micromachined or otherwise created in tubular member 20, and may be configured to make tubular member 20 more flexible in bending. The slots 24 may enhance the bending flexibility of the tubular member 20 without significantly reducing and/or hampering the torque transmission characteristics of the tubular member 20. Any of the above mentioned slots 24 can be formed in essentially any known way. For example, slots 24 can be formed by methods such as micro-machining, saw cutting (e.g., diamond grit embedded semiconductor dicing blade), laser cutting, grinding, milling, casting, molding, chemically etching or treating, electron discharge machining, or the like, or other known methods, and the like. Some example embodiments of appropriate micromachining methods and other cutting methods, and structures for tubular members including slots and medical devices including tubular members are disclosed in U.S. Pat. Publication Nos. US 2003/0069522; and US 2004/0181174-A2; and U.S. Pat. Nos. 6,766,720; and 6,579,246, the entire disclosures of which are herein incorporated by reference. Some example embodiments of etching processes are described in U.S. Pat. No. 5,106,455, the entire disclosure of which is herein incorporated by reference. It should be noted that the methods for manufacturing guidewire 10 may include forming slots 24 in tubular member 20 using any of these or other manufacturing steps.
Various embodiments of arrangements and configurations of slots 24 are contemplated. Slots 24 may be generally arranged to be perpendicular to the longitudinal axis of tubular member 20. This arrangement can, alternatively, be described as having slots 24 lying within a plane that is normal to the longitudinal axis of tubular member 20. In other embodiments, slots 24 may be formed at an angle relative to a plane that is normal to the longitudinal axis. In some embodiments, slots 24 may be formed part way through tubular member 20, while in other embodiments, slots 24 may extend all the way through tubular member 20. Any one or more of the individual slots 24 may extend only partially around the longitudinal axis of tubular member 20. In yet other embodiments, slots 24 may extend in a helical arrangement about the longitudinal axis of tubular member 20. Slots 24 may be formed in groups of two, three, or more slots 24, which may be located at substantially the same location along the axis of tubular member 20, and may be substantially perpendicular to the longitudinal axis. In other embodiments, only one slot 24, rather than a group of slots, may be disposed at one or more locations along the axis of tubular member 20. These embodiments may or may not include groups of slots 24 at other locations along the axis of tubular member 20.
The tubular member 20 may be included in the structure of the medical device to provide certain characteristics, for example, to enhance torque transmission, while still allowing for desired flexibility characteristics. When a tubular member, such as a slotted tubular member, is used in a medical device, it may be desirable to create a smooth transition in axial and torsional stiffness from a stiffer section of tubular member (e.g., an “unslotted” first section 20a of tubular member 20) to a more flexible section of tubular member (e.g., slotted section 20c of tubular member 20). This may help to reduce, for example, kinking that might otherwise occur at abrupt changes in flexibility. Some ways to establish this transition is to distally increase the frequency of slots 24, distally decrease the spacing of slots 24, distally increase the size of slots 24, or combinations thereof, or the like.
The embodiment shown in
The tapering of the tapered section 20c can be provided as desired, to achieve the desired transition. For example, the tapering can be provided in a linear, stepwise, curvilinear, or other fashion, as desired. In some embodiments, the flexibility characteristics of the tapered section 20b can be generally characterized as being intermediate to those of the first section 20a and the slotted section 20c, but generally, there is some transition of flexibility characteristics along the length of the tapered section 20b, moving from less flexibility adjacent the first section 20a to more flexibility adjacent the slotted section 20c. The transition can evolve from a flexibility that is at or near the flexibility of first section 20a, to a flexibility that is less than first section 20a, to a flexibility that approaches the flexibility of slotted section 20c. This arrangement of first section 20a, tapered section 20b, and slotted section 20c, thus, can create a desirable generally smooth transition in flexibility along the longitudinal axis of tubular member 20 between the sections 20a and 20c. Moreover, because first section 20a, tapered section 20b, and slotted section 20c, collectively, are generally made from a tubular material, tubular member 20 can provide the medical device 10 with an increased level of axial and/or torsional stiffness, while also providing the desired flexibility characteristics along its length.
Forming tapered section 20b, and/or other sections 20a and 20c of the tubular member 20, may include any one of a number of different techniques. For example, the sections of the tubular member 20, including the tapered section 20b, may be formed by centerless grinding methods, casting or forming methods, stamping methods, and the like. The centerless grinding technique may utilize an indexing system employing sensors (e.g., optical/reflective, magnetic) to avoid excessive grinding. In addition, the centerless grinding technique may utilize a CBN or diamond abrasive grinding wheel that is well shaped and dressed to avoid grabbing tubular member 20 during the grinding process. In some embodiments, tubular member 20 is centerless ground using a Royal Master HI-AC centerless grinder.
The materials that can be used for the various components of guidewire 10 may include those commonly associated with medical devices. For example, core wire 18 and/or tubular member 20 may be made from a metal, metal alloy, a metal-polymer composite, and the like, or any other suitable material. Some examples of suitable metals and metal alloys include stainless steel, such as 304V, 304L, and 316LV stainless steel such as 304V, 304L, and 316LV stainless steel; mild steel; nickel-titanium alloy such as linear-elastic and/or super-elastic nitinol; other nickel alloys such as nickel-chromium-molybdenum alloys (e.g., UNS: N06625 such as INCONEL® 625, UNS: N06022 such as HASTELLOY® C-22®, other HASTELLOY® alloys, and the like), nickel-chromium-iron alloy, nickel-copper alloys (e.g., UNS: N04400 such as MONEL® 400, NICKELVAC® 400, NICORROS® 400, and the like), nickel-cobalt-chromium-molybdenum alloys (e.g., UNS: R30035 such as MP35-N® and the like), other nickel-chromium alloys, other nickel-molybdenum alloys, other nickel-cobalt alloys, other nickel-iron alloys, other nickel-copper alloys, other nickel-tungsten alloys; tungsten or tungsten alloys; cobalt alloys, such as cobalt-chromium alloys; cobalt-chromium-molybdenum alloys (e.g., UNS: R30003 such as ELGILOY®, PHYNOX®, and the like); tungsten or tungsten alloys; platinum enriched stainless steel; 17-4PH®; 17-7PH®; 18Cr-2Ni-12Mn; 20Cb-3®; 21Cr-6Ni-9Mn; 22Cr-13Ni-5Mn302; 35N LT®; other stainless steels (e.g., 302, 304LV, 316LVM, 321, 347, etc.); 446A286; 455®; Alloy 31; Alloy 41; Alloy 600; Alloy 625; Alloy 718; Alloy 901; Alloy 902; Alloy B; Alloy X-750CCM®; Chromel; CONICHROME®; CP Ti Gr1; CP Ti Gr1HP; CP Ti Gr2; CP Ti Gr3; CP Ti Gr4 UnAlloyed (CP); Ti-Osteum®; Ti-3Al-2.5V; CUSTOM 455®; CUSTOM 465®; DBS®; DFT® (Composite); HASTELLOY Alloy C-4; HASTELLOY Alloy S; HASTELLOY Alloy X; HAYNES® 188; HAYNES 214™; HAYNES 230™; HAYNES 242™; HAYNES Alloy C-263; Hiperco 50B; INCONEL® Alloy 617; INCONEL Alloy 601; L605; Ni200; NIMONIC® 90; Platinum; Platinum-10 Iridium; Platinum-10 Nickel; Platinum-20 Iridium; Platinum-5 Iridium; Silver; Tantalum; Ti-13Zr-13Nb; Ti-3Al-8V-6Cr-4Zr-4Mo; Ti-6Al-4V ELI; Ti-6Al-4Zr-2Sn-2Mo; Ti-6Al-7Nb; Ti-8Al-1Mo-1V; ULTIMET®; WASPALOY®; combinations thereof; or the like; or any other suitable material.
As alluded to above, within the family of commercially available nickel-titanium or nitinol alloys, is a category designated “linear elastic” which, although it may be similar in chemistry to conventional shape memory and superelastic varieties, exhibits distinct and useful mechanical properties. By the applications of cold work, directional stress, and heat treatment, the material is fabricated in such a way that it does not display a substantial “superelastic plateau” or “flag region” in its stress/strain curve. Instead, as recoverable strain increases, the stress continues to increase in a generally linear relationship (as compared to that of super-elastic material, which has a super-elastic plateau) until plastic deformation begins. In some embodiments, the linear elastic nickel-titanium alloy is an alloy that does not show any substantial martensite/austenite phase changes that are detectable by DSC and DMTA analysis over a large temperature range.
For example, in some embodiments, there are no substantial martensite/austenite phase changes detectable by DSC and DMTA analysis in the range of about −60° C. to about 120° C. The mechanical bending properties of such material are therefore generally inert to the effect of temperature over this very broad range of temperature. In some particular embodiments, the mechanical properties of the alloy at ambient or room temperature are substantially the same as the mechanical properties at body temperature. In some embodiments, the use of the linear elastic nickel-titanium alloy allows the guidewire to exhibit superior “pushability” around tortuous anatomy. Accordingly, components of guidewire 10 such as core wire 18 and/or tubular member 20 may include linear elastic nickel-titanium alloy.
In some embodiments, the linear elastic nickel-titanium alloy is in the range of about 50 to about 60 weight percent nickel, with the remainder being essentially titanium. In some embodiments, the composition is in the range of about 54 to about 57 weight percent nickel. One example of a suitable nickel-titanium alloy is FHP-NT alloy commercially available from Furukawa Techno Material Co. of Kanagawa, Japan. Some examples of nickel titanium alloys are disclosed in U.S. Pat. Nos. 5,238,004 and 6,508,803, which are incorporated herein by reference. In some other embodiments, a superelastic alloy, for example a superelastic nitinol can be used to achieve desired properties.
In at least some embodiments, portions or all of core wire 18 and/or tubular member 20, or other components that are part of or used in the device, may be doped with, made of, or otherwise include a radiopaque material. Radiopaque materials are understood to be materials capable of producing a relatively bright image on a fluoroscopy screen or another imaging technique during a medical procedure. This relatively bright image aids the user of device 10 in determining its location. Some examples of radiopaque materials can include, but are not limited to, gold, platinum, palladium, tantalum, tungsten alloy, polymer material loaded with a radiopaque filler, and the like. Additionally, radiopaque marker bands and/or coils may be incorporated into the design of guidewire 10 to achieve the same result.
In some embodiments, a degree of MRI compatibility is imparted into device 10. For example, to enhance compatibility with Magnetic Resonance Imaging (MRI) machines, it may be desirable to make core wire 18 and/or tubular member 20, or other portions of the medical device 10, in a manner that would impart a degree of MRI compatibility. For example, core wire 18 and/or tubular member 20, or portions thereof, may be made of a material that does not substantially distort the image and create substantial artifacts (artifacts are gaps in the image). Certain ferromagnetic materials, for example, may not be suitable because they may create artifacts in an MRI image. Core wire 18 and/or tubular member 20, or portions thereof, may also be made from a material that the MRI machine can image. Some materials that exhibit these characteristics include, for example, tungsten, Elgiloy, MP35N, nitinol, and the like, and others.
Referring now to core wire 18, the entire core wire 18 can be made of the same material along its length, or in some embodiments, can include portions or sections made of different materials. In some embodiments, the material used to construct core wire 18 is chosen to impart varying flexibility and stiffness characteristics to different portions of core wire 18. For example, the proximal region and the distal region of core wire 18 may be formed of different materials, for example materials having different moduli of elasticity, resulting in a difference in flexibility. In some embodiments, the material used to construct the proximal region can be relatively stiff for pushability and torqueability, and the material used to construct the distal region can be relatively flexible by comparison for better lateral trackability and steerability. For example, the proximal region can be formed of straightened 304v stainless steel wire or ribbon and the distal region can be formed of a straightened super elastic or linear elastic alloy, for example a nickel-titanium alloy wire or ribbon.
In embodiments where different portions of core wire 18 are made of different materials, the different portions can be connected using any suitable connecting techniques. For example, the different portions of core wire 18 can be connected using welding (including laser welding), soldering, brazing, adhesive, or the like, or combinations thereof. Additionally, some embodiments can include one or more mechanical connectors or connector assemblies to connect the different portions of core wire 18 that are made of different materials. The connector may include any structure generally suitable for connecting portions of a guidewire. One example of a suitable structure includes a structure such as a hypotube or a coiled wire which has an inside diameter sized appropriately to receive and connect to the ends of the proximal portion and the distal portion. Some other examples of suitable techniques and structures that can be used to interconnect different shaft sections are disclosed in U.S. patent application Ser. No. 09/972,276 filed on Oct. 5, 2001, 10/086,992 filed on Feb. 28, 2002, and 10/375,766 filed on Feb. 26, 2003, which are incorporated herein by reference.
Core wire 18 can have a solid cross-section, but in some embodiments, can have a hollow cross-section. In yet other embodiments, core wire 18 can include a combination of areas having solid cross-sections and hollow cross sections. Moreover, core wire 18, or portions thereof, can be made of rounded wire, flattened ribbon, or other such structures having various cross-sectional geometries. The cross-sectional geometries along the length of core wire 18 can also be constant or can vary. For example,
Sheath 22 may be made from a polymer or any other suitable material. Some examples of suitable polymers may include polytetrafluoroethylene (PTFE), ethylene tetrafluoroethylene (ETFE), fluorinated ethylene propylene (FEP), polyoxymethylene (POM, for example, DELRIN® available from DuPont), polyether block ester, polyurethane, polypropylene (PP), polyvinylchloride (PVC), polyether-ester (for example, ARNITEL® available from DSM Engineering Plastics), ether or ester based copolymers (for example, butylene/poly(alkylene ether) phthalate and/or other polyester elastomers such as HYTREL® available from DuPont), polyamide (for example, DURETHAN® available from Bayer or CRISTAMID® available from Elf Atochem), elastomeric polyamides, block polyamide/ethers, polyether block amide (PEBA, for example available under the trade name PEBAX®), ethylene vinyl acetate copolymers (EVA), silicones, polyethylene (PE), Marlex high-density polyethylene, Marlex low-density polyethylene, linear low density polyethylene (for example REXELL®), polyester, polybutylene terephthalate (PBT), polyethylene terephthalate (PET), polytrimethylene terephthalate, polyethylene naphthalate (PEN), polyetheretherketone (PEEK), polyimide (PI), polyetherimide (PEI), polyphenylene sulfide (PPS), polyphenylene oxide (PPO), poly paraphenylene terephthalamide (for example, KEVLAR®), polysulfone, nylon, nylon-12 (such as GRILAMID® available from EMS American Grilon), perfluoro(propyl vinyl ether) (PFA), ethylene vinyl alcohol, polyolefin, polystyrene, epoxy, polyvinylidene chloride (PVdC), polycarbonates, ionomers, biocompatible polymers, other suitable materials, or mixtures, combinations, copolymers thereof, polymer/metal composites, and the like. In some embodiments sheath 22 can be blended with a liquid crystal polymer (LCP). For example, the mixture can contain up to about 6% LCP. This has been found to enhance torqueability. By employing selection of materials and processing techniques, thermoplastic, solvent soluble, and thermosetting variants of these and other materials can be employed to achieve the desired results.
In some embodiments, a coating, for example a lubricious, a hydrophilic, a protective, or other type of coating may be applied over portions or all of sheath 22, or in embodiments without a sheath 22, over portion of core wire 18 and/or tubular member, or other portions of device 10. Alternatively, sheath 22 may comprise a lubricious, hydrophilic, protective, or other type of coating. Hydrophobic coatings such as fluoropolymers may provide a dry lubricity which improves guidewire handling and device exchanges. Lubricious coatings may improve steerability and improve lesion crossing capability. Some examples of suitable coating materials may include silicone and the like, hydrophilic polymers such as high-density polyethylene (HDPE), polytetrafluoroethylene (PTFE), polyarylene oxides, polyvinylpyrolidones, polyvinylalcohols, hydroxy alkyl cellulosics, algins, saccharides, caprolactones, and the like, and mixtures and combinations thereof. Some coating polymers may be blended among themselves or with formulated amounts of water insoluble compounds (including some polymers) to yield coatings with suitable lubricity, bonding, and solubility. Some other examples of such coatings and materials and methods used to create such coatings can be found in U.S. Pat. Nos. 6,139,510 and 5,772,609, which are incorporated herein by reference.
The sheath 22 may be formed, for example, by coating, extrusion, co-extrusion, interrupted layer co-extrusion (ILC), heat bonding, shrink bonding, or fusing several segments end-to-end. The layer may have a uniform stiffness or a gradual reduction in stiffness from the proximal end to the distal end thereof. The gradual reduction in stiffness may be continuous as by ILC or may be stepped as by fusing together separate extruded tubular segments. The outer layer may be impregnated with a radiopaque filler material to facilitate radiographic visualization. Those skilled in the art will recognize that these materials can vary widely without deviating from the scope of the present invention. Any coating can also be formed and/or deposited using any suitable technique, such as spray coating, dip coating, or the like, or using any of the application techniques discussed above regarding the sheath 22.
It can also be seen in
Additionally, in some embodiments, the intermediate member 28 may function to secure the tubular member 20 with core wire 18. For example, in addition to being attached to the tubular member 20 and/or sections thereof, the intermediate member 28 may also be attached to the core wire 18, for example at bonding zone 27. The attachment of the intermediate member 28 to the core wire 18 can be made using a separate attachment technique, or can be made at the same time and/or using the same technique used to attach the tubular member 20 to the intermediate member 28. For example, in embodiments where a bonding material, such as an adhesive, solder, weld, or brazing material is used to make the attachment at the attachment zone 26, the material can be allowed to flow or wick between winding of coil 28 or otherwise flow from tubular member 20 onto coil 28 and into contact with core wire 18, thereby attaching the coil 28 to the core wire 18, and the coil to the tubular member 20. In such embodiments, the bonding zones 26 and 27 can essentially be formed using the same attachment technique or bonding material. Again, this type of arrangement can improve the attachment between tubular member 20 and core wire 18. A number of other structural components can be used for the intermediate member in place of the coil 28, such as a slotted or porous sleeve, jacket, or the like. The intermediate member, such as the coil 28, may extend distally to distal tip 11, proximally, for example to the proximal end of the tubular member 20, or beyond, or may end at any suitable location within the tubular member 20. It should be understood, however, that in some embodiments, the intermediate member 28 may not be attached to the core wire 18, or at least not attached to the core wire 18 at the longitudinal location of the bonding zone 26. In such embodiments, the core wire 18 may be at least somewhat free to move longitudinally relative to the intermediate member 28 and/or tubular member 20, for example, when the device is bent or flexed laterally. It should also be appreciated, that such an intermediate member 28 is not necessary in all embodiments, as will be discussed and illustrated further below.
While many of the embodiments discussed above relate to the use of such tubular members 20/120 in the construction of a guidewire, as indicated above, such members may also be used in other medical devices. In that regard, refer now to
The catheter 610 may also include a sheath 322 of one or more outer layers and/or members disposed about the tubular member 20. The one or more outer layers and/or members 322 may be made of any suitable materials, including those discussed herein, and in some embodiments, may be one or more layers or polymer material. Some examples of suitable polymer materials can include those discussed above regarding the sheath 22, and may be disposed about the tubular member 20 in any suitable manner, including any of those discussed above. The catheter may also include a coating material, for example, a lubricious, a hydrophilic, a protective, or other type of coating may be applied over portions or all of sheath 322 and/or the tubular member 20. The tubular member 20 may also include a surface treatment, such as those discussed above. Some examples of suitable coating materials include those discussed above. The catheter 610 can include a distal tip section 611 that may be defined by a distal portion of the inner tubular member 28, the sheath 322, or both, extending distally beyond and/or partially about the distal end of the tubular member 20. In some embodiments, additional material, such as a softer or more flexible polymer material can be added to the tip to provide a more atraumatic tip.
It should be understood that this disclosure is, in many respects, only illustrative. Changes may be made in details, particularly in matters of shape, size, and arrangement of steps without exceeding the scope of the invention. In addition, many of the structures, material, or methods or combinations thereof described or shown in one or more embodiments may be incorporated into other embodiments as desired. The invention's scope is, of course, defined in the language in which the appended claims are expressed.
This application is a continuation-in-part of U.S. patent application Ser. No. 10/604,504, filed Jul. 25, 2003, now U.S. Pat. Pub. No. US 2004/0181174, which claims priority to U.S. Provisional App. No. 60/399,046, filed Jul. 25, 2002, the disclosures of which are incorporated herein by reference.
Number | Name | Date | Kind |
---|---|---|---|
1553227 | Feyk et al. | Sep 1925 | A |
1866888 | Hawley | Jul 1932 | A |
2275827 | Plensler | Mar 1942 | A |
2413805 | Vickers | Jan 1947 | A |
2441166 | Raspert | May 1948 | A |
2561890 | Stoddard | Jul 1951 | A |
2722614 | Fryklund | Nov 1955 | A |
2857536 | Light | Oct 1958 | A |
2864017 | Waltscheff | Dec 1958 | A |
2871793 | Michie et al. | Feb 1959 | A |
3249776 | Anderson et al. | May 1966 | A |
3322984 | Anderson | May 1967 | A |
3334253 | Hill | Aug 1967 | A |
3363470 | Yavne | Jan 1968 | A |
3452227 | Welch | Jun 1969 | A |
3452742 | Muller | Jul 1969 | A |
3463953 | Maxwell | Aug 1969 | A |
3512019 | Durand | May 1970 | A |
3544868 | Bates | Dec 1970 | A |
3625200 | Muller | Dec 1971 | A |
3686990 | Margolien | Aug 1972 | A |
3841308 | Tate | Oct 1974 | A |
3890977 | Wilson | Jun 1975 | A |
3906938 | Fleischhacker | Sep 1975 | A |
4000672 | Sitterer et al. | Jan 1977 | A |
4003369 | Heilman et al. | Jan 1977 | A |
4020829 | Willson et al. | May 1977 | A |
4142119 | Madey | Feb 1979 | A |
4215703 | Wilson | Aug 1980 | A |
4330725 | Hintz | May 1982 | A |
4425919 | Alston, Jr. et al. | Jan 1984 | A |
4476754 | Ducret | Oct 1984 | A |
4482828 | Vergues et al. | Nov 1984 | A |
4545390 | Leary | Oct 1985 | A |
4563181 | Wijayarathna et al. | Jan 1986 | A |
4574670 | Johnson | Mar 1986 | A |
4580551 | Siegmund et al. | Apr 1986 | A |
4583404 | Bernard et al. | Apr 1986 | A |
4635270 | Gürs | Jan 1987 | A |
4665906 | Jervis | May 1987 | A |
4676249 | Arenas et al. | Jun 1987 | A |
4721117 | Mar et al. | Jan 1988 | A |
4737153 | Shimamura et al. | Apr 1988 | A |
4763647 | Gambale | Aug 1988 | A |
4774949 | Fogarty | Oct 1988 | A |
4781092 | Gaiser | Nov 1988 | A |
4781186 | Simpson et al. | Nov 1988 | A |
4786220 | Fildes et al. | Nov 1988 | A |
4790331 | Okada et al. | Dec 1988 | A |
4800890 | Cramer | Jan 1989 | A |
4811743 | Stevens | Mar 1989 | A |
4827941 | Taylor et al. | May 1989 | A |
4831858 | Yoshizawa | May 1989 | A |
4832047 | Sepetka et al. | May 1989 | A |
4846186 | Box et al. | Jul 1989 | A |
4846193 | Tremulis et al. | Jul 1989 | A |
4867173 | Leoni | Sep 1989 | A |
4875489 | Messner et al. | Oct 1989 | A |
4884579 | Engelson | Dec 1989 | A |
4911148 | Sosnowski et al. | Mar 1990 | A |
4917102 | Miller et al. | Apr 1990 | A |
4922164 | Jacobsen et al. | May 1990 | A |
4922777 | Kawabata | May 1990 | A |
4932959 | Horzewski et al. | Jun 1990 | A |
4934380 | Toledo | Jun 1990 | A |
4953553 | Tremulis | Sep 1990 | A |
4954022 | Underwood et al. | Sep 1990 | A |
4955384 | Taylor et al. | Sep 1990 | A |
4955862 | Sepetka | Sep 1990 | A |
4960410 | Pinchuk | Oct 1990 | A |
4964409 | Tremulis | Oct 1990 | A |
4966163 | Kraus et al. | Oct 1990 | A |
4968306 | Huss et al. | Nov 1990 | A |
4985022 | Fearnot et al. | Jan 1991 | A |
4989608 | Ratner | Feb 1991 | A |
4990143 | Sheridan | Feb 1991 | A |
4994069 | Ritchart et al. | Feb 1991 | A |
4998923 | Samson et al. | Mar 1991 | A |
5007434 | Doyle et al. | Apr 1991 | A |
5009137 | Dannatt | Apr 1991 | A |
5040543 | Badera et al. | Aug 1991 | A |
5050606 | Tremulis | Sep 1991 | A |
5052404 | Hodgson | Oct 1991 | A |
5059177 | Towne et al. | Oct 1991 | A |
5063935 | Gamble | Nov 1991 | A |
5065769 | De Toledo | Nov 1991 | A |
5095915 | Engelson | Mar 1992 | A |
5106455 | Jacobsen et al. | Apr 1992 | A |
5109830 | Cho | May 1992 | A |
5125395 | Adair | Jun 1992 | A |
5135531 | Shiber | Aug 1992 | A |
5144959 | Gambale et al. | Sep 1992 | A |
5147317 | Shank et al. | Sep 1992 | A |
5181668 | Tsuji et al. | Jan 1993 | A |
5205830 | Dassa et al. | Apr 1993 | A |
5211183 | Wilson | May 1993 | A |
5228441 | Lundquist | Jul 1993 | A |
5238004 | Sahatjian et al. | Aug 1993 | A |
5242759 | Hall | Sep 1993 | A |
5243996 | Hall | Sep 1993 | A |
5250069 | Nobuyoshi et al. | Oct 1993 | A |
5254106 | Feaster | Oct 1993 | A |
5254107 | Soltesz | Oct 1993 | A |
5256144 | Kraus et al. | Oct 1993 | A |
5257974 | Cox | Nov 1993 | A |
5259393 | Corso, Jr. et al. | Nov 1993 | A |
5267979 | Appling et al. | Dec 1993 | A |
5267982 | Sylvanowicz | Dec 1993 | A |
5279562 | Sirhan et al. | Jan 1994 | A |
5284128 | Hart | Feb 1994 | A |
5300032 | Hibbs et al. | Apr 1994 | A |
5304131 | Paskar | Apr 1994 | A |
5306252 | Yutori et al. | Apr 1994 | A |
5308435 | Ruggles et al. | May 1994 | A |
5315906 | Ferenczi et al. | May 1994 | A |
5315996 | Lundquist | May 1994 | A |
5318529 | Kontos | Jun 1994 | A |
5322064 | Lundquist | Jun 1994 | A |
5329923 | Lundquist | Jul 1994 | A |
5333620 | Moutafis et al. | Aug 1994 | A |
5334145 | Lundquist et al. | Aug 1994 | A |
5336205 | Zenzen et al. | Aug 1994 | A |
5341818 | Abrams et al. | Aug 1994 | A |
5345937 | Middleman et al. | Sep 1994 | A |
5345945 | Hodgson et al. | Sep 1994 | A |
5354623 | Hall | Oct 1994 | A |
5358493 | Schweich et al. | Oct 1994 | A |
5358796 | Nakamura et al. | Oct 1994 | A |
5365942 | Shank | Nov 1994 | A |
5365943 | Jansen | Nov 1994 | A |
5368564 | Savage | Nov 1994 | A |
5368661 | Nakamura et al. | Nov 1994 | A |
5376084 | Bacich et al. | Dec 1994 | A |
5381782 | DeLaRama et al. | Jan 1995 | A |
5406960 | Corso, Jr. | Apr 1995 | A |
5411476 | Abrams | May 1995 | A |
5437288 | Schwartz et al. | Aug 1995 | A |
5438993 | Lynch et al. | Aug 1995 | A |
5439000 | Gunderson et al. | Aug 1995 | A |
5441483 | Avitall | Aug 1995 | A |
5441489 | Utsumi et al. | Aug 1995 | A |
5447812 | Fukuda et al. | Sep 1995 | A |
5454787 | Lundquist | Oct 1995 | A |
5460187 | Daigle et al. | Oct 1995 | A |
5470330 | Goldenberg et al. | Nov 1995 | A |
5476701 | Berger | Dec 1995 | A |
5477856 | Lundquist | Dec 1995 | A |
5496294 | Hergenrother et al. | Mar 1996 | A |
5497785 | Viera | Mar 1996 | A |
5507301 | Wasicek et al. | Apr 1996 | A |
5507729 | Lindenberg et al. | Apr 1996 | A |
5507751 | Goode et al. | Apr 1996 | A |
5507766 | Kugo et al. | Apr 1996 | A |
5514128 | Hillsman et al. | May 1996 | A |
5520194 | Miyata et al. | May 1996 | A |
5520645 | Imran et al. | May 1996 | A |
5531719 | Takahashi | Jul 1996 | A |
5533985 | Wang | Jul 1996 | A |
5546958 | Thorud et al. | Aug 1996 | A |
5551444 | Finlayson | Sep 1996 | A |
5554139 | Okajima | Sep 1996 | A |
5562619 | Mirarchi et al. | Oct 1996 | A |
5569197 | Helmus et al. | Oct 1996 | A |
5569200 | Umeno et al. | Oct 1996 | A |
5569218 | Berg | Oct 1996 | A |
5571073 | Castillo | Nov 1996 | A |
5573520 | Schwartz et al. | Nov 1996 | A |
5584821 | Hobbs et al. | Dec 1996 | A |
5599326 | Carter | Feb 1997 | A |
5599492 | Engelson | Feb 1997 | A |
5601539 | Corso, Jr. | Feb 1997 | A |
5605162 | Mirzaee et al. | Feb 1997 | A |
5622184 | Ashby et al. | Apr 1997 | A |
5630806 | Inagaki et al. | May 1997 | A |
5637089 | Abrams et al. | Jun 1997 | A |
5656011 | Uihlein et al. | Aug 1997 | A |
5658264 | Samson et al. | Aug 1997 | A |
5666968 | Imran et al. | Sep 1997 | A |
5666969 | Urick et al. | Sep 1997 | A |
5669926 | Aust et al. | Sep 1997 | A |
5676659 | McGurk | Oct 1997 | A |
5676697 | McDonald | Oct 1997 | A |
5682894 | Orr et al. | Nov 1997 | A |
5690120 | Jacobsen et al. | Nov 1997 | A |
5720300 | Fagan et al. | Feb 1998 | A |
5722609 | Murakami | Mar 1998 | A |
5728063 | Preissman et al. | Mar 1998 | A |
5741429 | Donadio, III et al. | Apr 1998 | A |
5746701 | Noone | May 1998 | A |
5769830 | Parker | Jun 1998 | A |
5772609 | Nguyen et al. | Jun 1998 | A |
5782809 | Umeno et al. | Jul 1998 | A |
5788653 | Lorenzo | Aug 1998 | A |
5788654 | Schwager | Aug 1998 | A |
5788707 | Del Toro et al. | Aug 1998 | A |
5792124 | Horrigan et al. | Aug 1998 | A |
5797856 | Frisbie et al. | Aug 1998 | A |
5800454 | Jacobsen et al. | Sep 1998 | A |
5807075 | Jacobsen et al. | Sep 1998 | A |
5807249 | Qin et al. | Sep 1998 | A |
5810885 | Zinger | Sep 1998 | A |
5813996 | St. Germain et al. | Sep 1998 | A |
5827225 | Schwab | Oct 1998 | A |
5827242 | Follmer et al. | Oct 1998 | A |
5833632 | Jacobsen et al. | Nov 1998 | A |
5836926 | Peterson et al. | Nov 1998 | A |
5843050 | Jones et al. | Dec 1998 | A |
5843244 | Pelton et al. | Dec 1998 | A |
5851203 | van Muiden | Dec 1998 | A |
5895378 | Nita | Apr 1999 | A |
5897537 | Berg et al. | Apr 1999 | A |
5902254 | Magram | May 1999 | A |
5902290 | Peacock, III et al. | May 1999 | A |
5904657 | Unsworth et al. | May 1999 | A |
5906618 | Larson, III | May 1999 | A |
5911715 | Berg et al. | Jun 1999 | A |
5911717 | Jacobsen et al. | Jun 1999 | A |
5916177 | Schwager | Jun 1999 | A |
5916178 | Noone | Jun 1999 | A |
5916194 | Jacobsen et al. | Jun 1999 | A |
5931830 | Jacobsen et al. | Aug 1999 | A |
5935108 | Katoh et al. | Aug 1999 | A |
5947940 | Beisel | Sep 1999 | A |
5951539 | Nita et al. | Sep 1999 | A |
5971975 | Mills et al. | Oct 1999 | A |
5980471 | Jafari | Nov 1999 | A |
6001068 | Uchino et al. | Dec 1999 | A |
6004279 | Crowley et al. | Dec 1999 | A |
6014919 | Jacobsen et al. | Jan 2000 | A |
6017319 | Jacobsen et al. | Jan 2000 | A |
6022343 | Johnson et al. | Feb 2000 | A |
6022369 | Jacobsen et al. | Feb 2000 | A |
6024730 | Pagan | Feb 2000 | A |
6027461 | Walker et al. | Feb 2000 | A |
6042553 | Solar et al. | Mar 2000 | A |
6045547 | Ren et al. | Apr 2000 | A |
6048339 | Zirps et al. | Apr 2000 | A |
6056702 | Lorenzo | May 2000 | A |
6063101 | Jacobsen et al. | May 2000 | A |
6063200 | Jacobsen et al. | May 2000 | A |
6066361 | Jacobsen et al. | May 2000 | A |
6106485 | McMahon | Aug 2000 | A |
6106488 | Fleming et al. | Aug 2000 | A |
6139510 | Palermo | Oct 2000 | A |
6165292 | Abrams et al. | Dec 2000 | A |
6171296 | Chow | Jan 2001 | B1 |
6183410 | Jacobsen et al. | Feb 2001 | B1 |
6193686 | Estrada et al. | Feb 2001 | B1 |
6197014 | Samson et al. | Mar 2001 | B1 |
6203485 | Urick | Mar 2001 | B1 |
RE37148 | Shank | Apr 2001 | E |
6214042 | Jacobsen et al. | Apr 2001 | B1 |
6228073 | Noone et al. | May 2001 | B1 |
6248082 | Jafari | Jun 2001 | B1 |
6251092 | Qin et al. | Jun 2001 | B1 |
6254549 | Ramzipoor | Jul 2001 | B1 |
6260458 | Jacobsen et al. | Jul 2001 | B1 |
6273404 | Holman et al. | Aug 2001 | B1 |
6273876 | Klima et al. | Aug 2001 | B1 |
6273879 | Keith et al. | Aug 2001 | B1 |
6290656 | Boyle et al. | Sep 2001 | B1 |
6296616 | McMahon | Oct 2001 | B1 |
6296631 | Chow | Oct 2001 | B2 |
6302870 | Jacobsen et al. | Oct 2001 | B1 |
6325790 | Trotta | Dec 2001 | B1 |
6338725 | Hermann et al. | Jan 2002 | B1 |
6346091 | Jacobsen et al. | Feb 2002 | B1 |
6352515 | Anderson et al. | Mar 2002 | B1 |
6355005 | Powell et al. | Mar 2002 | B1 |
6355027 | Le et al. | Mar 2002 | B1 |
6368315 | Gillis et al. | Apr 2002 | B1 |
6368316 | Jansen et al. | Apr 2002 | B1 |
6375628 | Zadno-Azizi et al. | Apr 2002 | B1 |
6375774 | Lunn et al. | Apr 2002 | B1 |
6379369 | Abrams et al. | Apr 2002 | B1 |
6390993 | Cornish et al. | May 2002 | B1 |
6398758 | Jacobsen et al. | Jun 2002 | B1 |
6428489 | Jacobsen et al. | Aug 2002 | B1 |
6428512 | Anderson et al. | Aug 2002 | B1 |
6431039 | Jacobsen et al. | Aug 2002 | B1 |
6440088 | Jacobsen | Aug 2002 | B1 |
6478778 | Jacobsen et al. | Nov 2002 | B1 |
6488637 | Eder et al. | Dec 2002 | B1 |
6491648 | Cornish et al. | Dec 2002 | B1 |
6491671 | Larson, III et al. | Dec 2002 | B1 |
6503244 | Hayman | Jan 2003 | B2 |
6508803 | Horikawa et al. | Jan 2003 | B1 |
6524301 | Wilson et al. | Feb 2003 | B1 |
6530934 | Jacobsen et al. | Mar 2003 | B1 |
6547779 | Levine et al. | Apr 2003 | B2 |
6553880 | Jacobsen et al. | Apr 2003 | B2 |
6556873 | Smits | Apr 2003 | B1 |
6579246 | Jacobsen et al. | Jun 2003 | B2 |
6602207 | Mann et al. | Aug 2003 | B1 |
6602280 | Chobotov | Aug 2003 | B2 |
6610046 | Usami et al. | Aug 2003 | B1 |
6623448 | Slater | Sep 2003 | B2 |
6636758 | Sanchez et al. | Oct 2003 | B2 |
6638266 | Wilson et al. | Oct 2003 | B2 |
6652508 | Griffin et al. | Nov 2003 | B2 |
6682493 | Mirigian | Jan 2004 | B2 |
6689120 | Gerdts | Feb 2004 | B1 |
6702762 | Jafari et al. | Mar 2004 | B2 |
6712826 | Lui | Mar 2004 | B2 |
6730095 | Olson, Jr. et al. | May 2004 | B2 |
6749560 | Konstorum et al. | Jun 2004 | B1 |
6766720 | Jacobsen et al. | Jul 2004 | B1 |
6777644 | Peacock, III et al. | Aug 2004 | B2 |
6811544 | Schaer | Nov 2004 | B2 |
6837898 | Boyle et al. | Jan 2005 | B2 |
6866642 | Kellerman et al. | Mar 2005 | B2 |
6887235 | O'Connor et al. | May 2005 | B2 |
6918882 | Skujins et al. | Jul 2005 | B2 |
6997937 | Jacobsen et al. | Feb 2006 | B2 |
7001369 | Griffin et al. | Feb 2006 | B2 |
7074197 | Reynolds et al. | Jul 2006 | B2 |
7153277 | Skujins et al. | Dec 2006 | B2 |
7182735 | Shireman et al. | Feb 2007 | B2 |
7494687 | Cox | Feb 2009 | B2 |
20020013540 | Jacobsen et al. | Jan 2002 | A1 |
20020019599 | Rooney et al. | Feb 2002 | A1 |
20030009208 | Snyder et al. | Jan 2003 | A1 |
20030060732 | Jacobsen et al. | Mar 2003 | A1 |
20030069522 | Jacobsen et al. | Apr 2003 | A1 |
20030216668 | Howland et al. | Nov 2003 | A1 |
20040116831 | Vrba | Jun 2004 | A1 |
20040142643 | Miller et al. | Jul 2004 | A1 |
20040167436 | Reynolds et al. | Aug 2004 | A1 |
20040167437 | Sharrow et al. | Aug 2004 | A1 |
20040167441 | Reynolds et al. | Aug 2004 | A1 |
20040181174 | Davis et al. | Sep 2004 | A2 |
20040181176 | Jafari et al. | Sep 2004 | A1 |
20040210163 | Osawa et al. | Oct 2004 | A1 |
20060121218 | Obara et al. | Jun 2006 | A1 |
20060122537 | Reynolds et al. | Jun 2006 | A1 |
20060189896 | Davis et al. | Aug 2006 | A1 |
20060264904 | Kerby et al. | Nov 2006 | A1 |
20080021347 | Jacobsen et al. | Jan 2008 | A1 |
20080021348 | Jacobsen et al. | Jan 2008 | A1 |
20080021400 | Jacobsen et al. | Jan 2008 | A1 |
20080021401 | Jacobsen et al. | Jan 2008 | A1 |
20080021402 | Jacobsen et al. | Jan 2008 | A1 |
20080021403 | Jacobsen et al. | Jan 2008 | A1 |
20080021404 | Jacobsen et al. | Jan 2008 | A1 |
20080021405 | Jacobsen et al. | Jan 2008 | A1 |
20080021406 | Jacobsen et al. | Jan 2008 | A1 |
20080021407 | Jacobsen et al. | Jan 2008 | A1 |
20080021408 | Jacobsen et al. | Jan 2008 | A1 |
20080077119 | Snyder et al. | Mar 2008 | A1 |
Number | Date | Country |
---|---|---|
723040 | Dec 1997 | AU |
733966 | Apr 1998 | AU |
PI 9712829 | Jan 2000 | BR |
2266685 | May 2006 | CA |
2255781 | Mar 2007 | CA |
1230914 | Oct 1999 | CN |
2539191 | Mar 1976 | DE |
285514 | Dec 1990 | DE |
0 045 931 | Feb 1982 | EP |
0 069 522 | Jan 1983 | EP |
0 087 933 | Sep 1983 | EP |
0 111 044 | Jun 1984 | EP |
0 181 174 | May 1986 | EP |
0 377 453 | Jul 1990 | EP |
0 565 065 | Jun 1996 | EP |
0 778 038 | Jun 1997 | EP |
0 778 039 | Jun 1997 | EP |
0 778 040 | Jun 1997 | EP |
0 812 599 | Dec 1997 | EP |
0 865 772 | Sep 1998 | EP |
0 865 773 | Sep 1998 | EP |
0 521 595 | May 1999 | EP |
0 917 885 | May 1999 | EP |
0 937 481 | Aug 1999 | EP |
0 790 066 | Apr 2000 | EP |
0 608 853 | Apr 2003 | EP |
0 935 947 | Dec 2004 | EP |
0 934 141 | Nov 2005 | EP |
2214354 | Aug 1989 | GB |
2257269 | Jan 1993 | GB |
58-8522 | Jan 1983 | JP |
60091858 | May 1985 | JP |
61022752 | Jan 1986 | JP |
62023361 | Jan 1987 | JP |
62089470 | Apr 1987 | JP |
62299277 | Dec 1987 | JP |
6393516 | Apr 1988 | JP |
63-181774 | Jul 1988 | JP |
63217966 | Sep 1988 | JP |
1089956 | Apr 1989 | JP |
1135363 | May 1989 | JP |
1158936 | Jun 1989 | JP |
2107268 | Apr 1990 | JP |
3081831 | Apr 1991 | JP |
03-122850 | Dec 1991 | JP |
4061840 | Feb 1992 | JP |
4099963 | Mar 1992 | JP |
4213069 | Aug 1992 | JP |
4213070 | Aug 1992 | JP |
4236965 | Aug 1992 | JP |
5149969 | Jun 1993 | JP |
5-506806 | Oct 1993 | JP |
5-309519 | Nov 1993 | JP |
5-507857 | Nov 1993 | JP |
6-501179 | Feb 1994 | JP |
631749 | Apr 1994 | JP |
6169996 | Jun 1994 | JP |
6-63224 | Sep 1994 | JP |
6312313 | Nov 1994 | JP |
728562 | May 1995 | JP |
7124164 | May 1995 | JP |
7124263 | May 1995 | JP |
7136280 | May 1995 | JP |
7148264 | Jun 1995 | JP |
7505561 | Jun 1995 | JP |
7037199 | Jul 1995 | JP |
7185009 | Jul 1995 | JP |
7255855 | Oct 1995 | JP |
7275366 | Oct 1995 | JP |
751067 | Nov 1995 | JP |
8-229888 | Sep 1996 | JP |
8509141 | Oct 1996 | JP |
8317988 | Dec 1996 | JP |
9000164 | Apr 1997 | JP |
9-276413 | Oct 1997 | JP |
9276413 | Oct 1997 | JP |
9-294813 | Nov 1997 | JP |
9294813 | Nov 1997 | JP |
10-118193 | May 1998 | JP |
10328191 | Dec 1998 | JP |
11-267224 | Oct 1999 | JP |
2000-197704 | Jul 2000 | JP |
2000-510722 | Aug 2000 | JP |
2000-511083 | Aug 2000 | JP |
2001-500808 | Jan 2001 | JP |
3325828 | Jul 2002 | JP |
2002-529137 | Sep 2002 | JP |
2002-542901 | Dec 2002 | JP |
2002-543896 | Dec 2002 | JP |
2003-517893 | Jun 2003 | JP |
3649604 | Feb 2005 | JP |
2005-534407 | Nov 2005 | JP |
712908 | Jan 1980 | SU |
758421 | Aug 1980 | SU |
1529365 | Dec 1989 | SU |
WO 9002520 | Mar 1990 | WO |
WO 9113364 | Sep 1991 | WO |
WO 9204072 | Mar 1992 | WO |
WO 9207619 | May 1992 | WO |
WO 9304722 | Mar 1993 | WO |
WO 9311313 | Jun 1993 | WO |
WO 9524236 | Sep 1995 | WO |
WO 9619255 | Jun 1996 | WO |
WO 9710022 | Mar 1997 | WO |
WO 9725914 | Jul 1997 | WO |
WO 9743949 | Nov 1997 | WO |
WO 9744083 | Nov 1997 | WO |
WO 9744086 | Nov 1997 | WO |
WO 9810694 | Mar 1998 | WO |
WO 9904847 | Feb 1999 | WO |
WO 9911313 | Mar 1999 | WO |
WO 0027303 | May 2000 | WO |
WO 0030710 | Jun 2000 | WO |
WO 0048645 | Aug 2000 | WO |
WO 0057943 | Oct 2000 | WO |
WO 0066199 | Nov 2000 | WO |
WO 0067845 | Nov 2000 | WO |
WO 0072907 | Dec 2000 | WO |
WO 0128620 | Apr 2001 | WO |
WO 0136034 | May 2001 | WO |
0145912 | Jun 2001 | WO |
WO 0145773 | Jun 2001 | WO |
WO 0193920 | Dec 2001 | WO |
WO 0213682 | Feb 2002 | WO |
WO 02062540 | Aug 2002 | WO |
WO 03004086 | Jan 2003 | WO |
WO 03008148 | Jan 2003 | WO |
WO 2004012804 | Feb 2004 | WO |
2004047899 | Jun 2004 | WO |
Number | Date | Country | |
---|---|---|---|
20070287955 A1 | Dec 2007 | US |
Number | Date | Country | |
---|---|---|---|
60399046 | Jul 2002 | US |
Number | Date | Country | |
---|---|---|---|
Parent | 10604504 | Jul 2003 | US |
Child | 11836039 | US |